» Articles » PMID: 39852392

The Current Applications of Metabolomics in Understanding Endometriosis: A Systematic Review

Overview
Journal Metabolites
Publisher MDPI
Date 2025 Jan 24
PMID 39852392
Authors
Affiliations
Soon will be listed here.
Abstract

Endometriosis is a common gynecological disease that affects approximately 10-15% of reproductive-aged women worldwide. This debilitating disease has a negative impact on the quality of life of those affected. Despite this condition being very common, the pathogenesis is not well understood. Metabolomics is the study of the array of low-weight metabolites in a given sample. This emerging field of omics-based science has proved to be effective at furthering the understanding of endometriosis. In this systematic review, we seek to provide an overview of the application of metabolomics in endometriosis. We highlight the use of metabolomics in locating biomarkers for identification, understanding treatment mechanisms and symptoms, and relating external factors to endometriosis. The literature search took place in the Web of Science, Pubmed, and Google Scholar based on the keywords "metabolomics" AND "endometriosis" or "metabolome" AND "endometriosis". We found 58 articles from 2012 to 2024 that met our search criteria. Significant alterations of lipids, amino acids, as well as other compounds were present in human and animal models. Discrepancies among studies of significantly altered metabolites make it difficult to make general conclusions on the metabolic signature of endometriosis. However, several individual metabolites were elevated in multiple studies of women with endometriosis; these include 3-hydroxybutyrate, lactate, phosphatidic acids, succinate, pyruvate, tetradecenoylcarnitine, hypoxanthine, and xanthine. Accordingly, L-isoleucine and citrate were reduced in multiple studies of women with endometriosis. Including larger cohorts, standardizing testing methods, and studying the individual phenotypes of endometriosis may lead to more separable results.

References
1.
Li J, Guan L, Zhang H, Gao Y, Sun J, Gong X . Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages. Reprod Biol Endocrinol. 2018; 16(1):42. PMC: 5928574. DOI: 10.1186/s12958-018-0360-z. View

2.
Ni Z, Sun S, Bi Y, Ding J, Cheng W, Yu J . Correlation of fecal metabolomics and gut microbiota in mice with endometriosis. Am J Reprod Immunol. 2020; 84(6):e13307. DOI: 10.1111/aji.13307. View

3.
Bouet P, Chao de la Barca J, El Hachem H, Descamps P, Legendre G, Reynier P . Metabolomics shows no impairment of the microenvironment of the cumulus-oocyte complex in women with isolated endometriosis. Reprod Biomed Online. 2019; 39(6):885-892. DOI: 10.1016/j.rbmo.2019.08.001. View

4.
Wei Y, Zhang Z, Zhang Y, Li J, Ruan X, Wan Q . Nontargeted metabolomics analysis of follicular fluid in patients with endometriosis provides a new direction for the study of oocyte quality. MedComm (2020). 2023; 4(3):e302. PMC: 10229744. DOI: 10.1002/mco2.302. View

5.
Guo H, Zhu Q, Gao H, Lyu Q, Chai W, Wu L . Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization. Sci Rep. 2023; 13(1):5747. PMC: 10082198. DOI: 10.1038/s41598-023-32797-w. View